Ingenus Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 6 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Ingenus Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ingenus-pharmaceuticals

Overview

Ingenus Pharmaceuticals is a pharmaceutical company headquartered in Orlando, United States.

FDA compliance signals

6 FDA enforcement records linked to this company.

  • recall — Class II2022-10-26

    Out of specification for related substances (impurities).

  • recall — Class II2022-01-26

    CGMP Deviations

  • recall — Class II2019-10-23

    Crystallization: Presence of particulate matter identified as API crystallization

  • recall — Class III2019-04-03

    Defective Container: firm discovered samples stored horizontally as well as product quality complaints from customers for bottles leaking.

  • recall — Class II2018-07-11

    Superpotent Drug: High out of specification assay value results for potency.

  • recall — Class II2018-07-11

    Superpotent Drug: High out of specification assay value results for potency.

For suppliers

Is this Ingenus Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.